Influential shareholder advisory firm Institutional Shareholder Services recommended in a report that Biomet Inc. shareholders vote against a $10.9 billion private-equity buyout of the orthopedic device maker, saying the price is not high enough.
*For more on this story,
read the full Reuters article.
